We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's Proposed User Fee for Reinspections Is Unique, HELP Staff Says
FDA's Proposed User Fee for Reinspections Is Unique, HELP Staff Says
March 6, 2006
A key Senate committee that oversees the FDA hasn’t decided whether it will support the agency’s proposed industry user fee for reinspections of manufacturing facilities, questioning what it sees as a “unique” approach to increasing FDA funding.